Deanna B. van Gestel

Deanna van Gestel is a seasoned professional with extensive experience in the oncology and pharmaceutical sectors. Since March 2007, Deanna has served as CEO of Vaniam Group LLC. In addition to leadership at Vaniam Group, Deanna is a board member for Conquer Cancer, the ASCO Foundation as of March 2021. Previous roles include positions in oncology medical affairs at Cell Therapeutics, Inc., oncology market development at Genta, and sales positions at Immunex, Allergan, and Schwarz Pharma. Deanna holds a Bachelor of Science degree in Journalism from Eastern Michigan University.